S
Sana Biotechnology Inc
NASDAQ:SANA
Sana Biotechnology Inc
NASDAQ:SANA
Price:
4.1
USD
-7.03%
Market Cap:
$1.1B
Balance Sheet
Balance Sheet Decomposition
Sana Biotechnology Inc
Sana Biotechnology Inc
Balance Sheet Decomposition is not available for
Sana Biotechnology Inc
Sana Biotechnology Inc
Balance Sheet
Sana Biotechnology Inc
Sana Biotechnology Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
31
|
80
|
125
|
253
|
177
|
134
|
128
|
|
| Cash Equivalents |
31
|
80
|
125
|
253
|
177
|
134
|
128
|
|
| Short-Term Investments |
0
|
59
|
254
|
298
|
247
|
72
|
25
|
|
| Other Current Assets |
2
|
5
|
6
|
7
|
21
|
8
|
8
|
|
| Total Current Assets |
33
|
144
|
385
|
558
|
444
|
214
|
161
|
|
| PP&E Net |
1
|
69
|
110
|
162
|
159
|
146
|
135
|
|
| PP&E Gross |
1
|
69
|
110
|
162
|
159
|
146
|
135
|
|
| Accumulated Depreciation |
0
|
2
|
8
|
19
|
34
|
42
|
54
|
|
| Intangible Assets |
0
|
59
|
59
|
59
|
59
|
59
|
59
|
|
| Goodwill |
0
|
141
|
141
|
141
|
141
|
141
|
141
|
|
| Long-Term Investments |
0
|
0
|
34
|
196
|
10
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
2
|
2
|
14
|
9
|
6
|
5
|
|
| Other Assets |
0
|
141
|
141
|
141
|
141
|
141
|
141
|
|
| Total Assets |
34
N/A
|
415
+1 110%
|
730
+76%
|
1 129
+55%
|
823
-27%
|
565
-31%
|
501
-11%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
2
|
2
|
3
|
4
|
5
|
|
| Accrued Liabilities |
1
|
18
|
26
|
38
|
50
|
58
|
38
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
2
|
4
|
59
|
58
|
3
|
2
|
|
| Total Current Liabilities |
2
|
19
|
32
|
99
|
112
|
64
|
45
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
121
|
267
|
302
|
212
|
213
|
205
|
|
| Total Liabilities |
2
N/A
|
140
+7 700%
|
299
+113%
|
401
+34%
|
323
-19%
|
278
-14%
|
251
-10%
|
|
| Equity | ||||||||
| Common Stock |
46
|
417
|
853
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
13
|
144
|
429
|
785
|
1 055
|
1 338
|
1 605
|
|
| Additional Paid In Capital |
0
|
2
|
8
|
1 515
|
1 559
|
1 626
|
1 855
|
|
| Other Equity |
0
|
0
|
0
|
1
|
4
|
0
|
0
|
|
| Total Equity |
33
N/A
|
275
+746%
|
432
+57%
|
729
+69%
|
499
-31%
|
288
-42%
|
251
-13%
|
|
| Total Liabilities & Equity |
34
N/A
|
415
+1 110%
|
730
+76%
|
1 129
+55%
|
823
-27%
|
565
-31%
|
501
-11%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
184
|
184
|
184
|
185
|
191
|
198
|
224
|
|
Switch to:
Switch to:
See Also
Discover More
